Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE

The Vanguard Group's stake in Monte Rosa Therapeutics, Inc. fell to 4.83% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Oct 31, 2025

The Vanguard Group's stake in Monte Rosa Therapeutics, Inc. fell to 4.83%, 2,988,953 shares, as a passive investor on Sep 30, 2025. Filed Oct 31, 2025 (Schedule 13G/A).

Stake
4.83%
Shares
2,988,953
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
The Vanguard Group4.83%2,988,953

Source

View original at SEC

Related